Structure |
Chemical Name |
CAS |
MF |
![sodium (41S,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12, 13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5] naphthyridine-12-carboxylate](/CAS/20211123/GIF/53448-45-6.gif) |
sodium (41S,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12, 13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5] naphthyridine-12-carboxylate |
53448-45-6 |
C20H24N2O3 |
 |
methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate |
1181267-33-3 |
C13H17ClO2 |
 |
Rivaroxaban Impurity 35 |
2206360-74-7 |
C23H24N4O6 |
 |
(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
150194-52-8 |
C11H10BrF2N3O |
 |
Tirofiban hydrochloride monohydrate Impurity 7 |
2250244-28-9 |
C13H19NO5S |
 |
Imidafenacin Related Compound 7 |
191592-57-1 |
C16H13N |
![(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide](/CAS/20180703/GIF/CB93049205.gif) |
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |
 |
Etoricoxib Impurity 18 |
|
|
 |
17α-(シアノメチル)エストラ-1,3,5(10)-トリエン-3,17β-ジオール |
16669-06-0 |
C20H25NO2 |
 |
Cefaclor Impurity 6 |
|
|
 |
Ibrutinib Impurity 4 |
1807619-68-6 |
C17H12ClN5O |
 |
Imatinib Impurity 3 |
|
|
 |
Cephalexin Impurity 6 |
|
C16H17N3O4S |
 |
Mirabegron Impurity 16 |
|
|
 |
Pitavastatin Impurity 42 |
|
|
 |
Olaparib Impurity 2 |
|
|
 |
Rocuronium bromide Impurity J |
|
C32H53BrN2O4 |
 |
Sofosbuvir Impurity 7 |
1884385-12-9 |
C20H19FO6 |
 |
Tofacitinib Impurity 72 |
|
|
 |
Tofacitinib Impurity 81 |
|
|
 |
Topiroxostat Impurity 9 |
2044708-04-3 |
C7H10N6O |
 |
Vinorelbine EP Impurity C |
|
|
 |
Aztreonam Impurity 2 |
|
|
 |
Benazepril Impurity E |
|
C24H28N2O5 |
 |
Canagliflozin Impurity 44 |
|
|
 |
Clotrimazole Impurity 3 |
|
|
 |
Dithio-Desethyl Carbodenafil |
1610830-81-3 |
C22H28N6OS2 |
 |
Erlotinib Impurity 57 |
|
|
 |
Oseltamivir Impurity 29 |
|
|
 |
Pramipexole Impurity 36 |
|
|
 |
Riboflavin Impurity 1 |
64480-68-8 |
C16H20N2O7 |
 |
Rocuronium Bromide Impurity 10 |
|
|
 |
Rocuronium Bromide Impurity 23 |
|
C23H39NO3 |
 |
Cefoxitin EP Impurity G |
|
|
 |
Dextrorotation lansoprazole Impurity L |
|
|
 |
lansoprazole Impurity 25 |
|
|
 |
Mirabegron Enantiomer Impurity |
|
|
 |
Ropivacaine Impurity 44 |
|
|
 |
Ropivacaine Impurity 7 |
|
|
 |
Sugammadex sodium Org199010-1 Impurity |
|
|
 |
Sugammadex sodium Org226100-1 Impurity |
|
|
 |
Butyphthalide impurity 26 |
|
|
 |
Butyphthalide impurity 32 |
|
|
 |
Canagliflozin Impurity 30 |
|
|
 |
Celecoxib Impurity 20 |
343853-74-7 |
C6H7N3O3S |
 |
Emtricitabine Impurity CFTU1 |
|
|
 |
Febuxostat Impurity 82 |
|
|
 |
Febuxostat Impurity 87 |
|
|
 |
Vonoprazan Impurity 3 |
928325-41-1 |
C17H15F2N3O2S |
 |
Cinacalcet Impurity 22 |
|
|
 |
Dapagliflozin Impurity C |
|
|
 |
Dasatinib Impurity E |
|
|
 |
Ixazomib Impurity |
|
|
 |
Nevirapine Impurity |
|
|
 |
Gefitinib Impurity R |
|
|
 |
Imatinib impurity 31 |
1356565-47-3 |
C17H17N7 |
 |
LCZ696(valsartan + sacubitril) impurity 33 |
|
|
 |
Lenvatinib Impurity 26 |
|
|
 |
Ozagrel impurity C |
|
|
 |
Regorafenib Impurity 24 |
|
|
 |
Regorafenib Impurity 32 |
|
|
 |
Sitafloxacin Impurity ZZ-A-01 |
|
|
 |
Solifenacin impurity 18 |
1243274-83-0 |
C14H17NO3 |
 |
Tofacitinib Impurity 87 |
|
|
 |
Tofacitinib Impurity 92 |
|
|
 |
Amlodipine EP Impurity K |
|
C26H31ClN2O8S |
 |
Febuxostat Impurity 49 |
|
|
 |
Budesonide Impurity 6 |
131918-73-5 |
C21H26O6 |
 |
Timolol Impurity 1 |
75014-25-4 |
C13H24N4O5S |
 |
Telmisartan EP-J |
885045-90-9 |
C33H29ClN4O2 |
 |
Pitavastatin Impurity 29 |
148516-15-8 |
C25H20FNO2 |
 |
Rosuvastatin Related Compound 6 |
521973-99-9 |
C13H23ClO4 |
 |
Medetomidine impurity |
2250243-44-6 |
C20H22N2O |
 |
Linagliptin Impurity 51 |
|
|
 |
Carfilzomib Impurity YGF |
|
|
 |
Pitavastatin Impurity 45 |
1258947-29-3 |
C29H32FNO4 |
 |
Irinotecan Impurity L |
|
|
 |
Irinotecan Impurity H |
|
|
 |
LCZ696(valsartan + sacubitril) impurity 27 |
|
|
 |
Caspofungin Impurity EJT2 |
|
|
 |
Tofacitinib Impurity 100 |
|
|
 |
Omarigliptin Impurity |
1819364-01-6 |
C16H18F2N4O |
 |
Palbociclib Impurity 8 |
827022-31-1 |
C31H41N7O4 |
 |
Sitagliptin EP Impurity C |
1345822-86-7 |
C16H19F5N5O5P |
 |
Trifluridine Impurity |
2086328-10-9 |
C10H11F3N2O5 |
 |
Valsartan related compound H |
|
|
 |
Vildagliptin Related Compound H |
2253194-13-5 |
C12H16N4O |
 |
Moxifloxacin Impurity 7 |
|
|
![(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one](/CAS/20180703/GIF/869478-12-6.gif) |
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one |
869478-12-6 |
C17H15NO4 |
 |
Merariveron impurity D |
|
C26H28N6O3S2 |
 |
Cefazolin impurity E |
|
|
 |
Lamivudine Impurity Mixture |
|
|
 |
Rifaximin impurity B |
1351775-04-6 |
C43H49N3O11 |
 |
4-(3-(Piperidin-1-yl)propoxy)benzoic acid |
767286-87-3 |
C15H21NO3 |
 |
5-Chloro-3-sulfino-2-thiophenecarboxylic acid |
187746-97-0 |
C5H3ClO4S2 |
![ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](/CAS/20180703/GIF/431058-46-7.gif) |
ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
431058-46-7 |
C15H14FNO4 |
 |
methyl (Z)-3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C24H21N3O3 |
 |
Isavuconazole Impurity 11 |
2732924-99-9 |
C10H16ClN3O2 |
 |
Levosimendan Impurity 2 |
103416-88-2 |
C11H12N2O2 |
 |
Famotidine EP Impurity A |
88061-72-7 |
C8H15N7O2S3 |